Market Access Issues
Market Access Issues Hindering Specialists’ Use of Advanced Systemics in Lupus Nephritis
July 27, 2023 16:00 ET | Spherix Global Insights
Exton, Pennsylvania, July 27, 2023 (GLOBE NEWSWIRE) -- While the approvals of GSK’s Benlysta (belimumab) and Aurinia’s Lupkynis (voclosporin) have provided rheumatologists and nephrologists with...
cmi_logo.png
[Latest] Global Women’s Health Diagnostics Market Size/Share Worth USD 45.4 Billion by 2032 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 18, 2023 04:30 ET | Custom Market Insights
Austin, TX, USA, July 18, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Women’s Health Diagnostics Market Size, Trends and Insights By Application...
cmi_logo.png
[Latest] Global Water Treatment Equipment Market Size/Share Worth USD 96.7 Billion by 2032 at a 6.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 14, 2023 13:30 ET | Custom Market Insights
Austin, TX, USA, July 14, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Water Treatment Equipment Market Size, Trends and Insights By Type (Process...
ihl_logo.png
Incannex Announces Intention to Redomicile to United States, List all Shares on Nasdaq
July 10, 2023 07:30 ET | Incannex Healthcare
Highlights: Incannex to redomicile to the United States via a Scheme of Arrangement pursuant to Australian lawA newly formed Delaware corporation (Incannex Healthcare Inc.) will become the ultimate...
IGadgets Collaborates with Lumaflex to Market the World's First Portable, Waterproof, Flexible Red Light Therapy Device
July 06, 2023 07:57 ET | IGadgets
GARDEN GROVE, Calif., July 06, 2023 (GLOBE NEWSWIRE) -- IGadgets announces a collaboration with Lumaflex, the creator of the world's first portable, waterproof red light therapy device. IGadgets has...
Logo.png
GRI Bio (NASDAQ: GRI) Bolsters Patent Portfolio
June 27, 2023 08:45 ET | GRI Bio, Inc.
- U.S. patent issuance for lead program, GRI-0621, in development for the treatment of idiopathic pulmonary fibrosis (IPF) - Company building a robust global patent estate LA JOLLA, CA, June...
Dimensions Announces Ground-breaking Therapeutic Program for Veterans
June 07, 2023 10:00 ET | Dimensions Health Centres
TORONTO, June 07, 2023 (GLOBE NEWSWIRE) -- Dimensions, has announced that Veterans Affairs Canada (VAC) has officially approved their ELEVATE for Veterans-Only Program as a VAC Interdisciplinary...
Logo.png
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Award for Novel Cancer Immunotherapy Treatment, Granted for Prostate Cancer, Colon Cancer, Ovarian Cancer, Kidney Cancer, Breast Cancer, Glioblastoma, Melanoma, and Lung Cancer.
May 23, 2023 08:01 ET | Ocean Biomedical, Inc.
Latest patent broadens protection around OCEA’s platform of first-in-class anti-CHi3L1 therapeutic immunotherapy candidates, based on the breakthrough discovery by scientific co-founder, Dr. Jack A....
logo.png
GRI Bio (NASDAQ: GRI) Provides Business Outlook and Highlights Upcoming Milestones for Innovative Pipeline of NKT Cell Modulators
May 22, 2023 08:45 ET | GRI Bio, Inc.
Rapidly advancing clinical pipeline in potential high-value inflammatory, fibrotic and autoimmune diseases Leading NKT regulation technology targeting earlier in the inflammatory cascade to...
MS_Photo
Mount Sinai Brooklyn Expands Cancer Services, Infusion Center in $4 Million Project
May 19, 2023 14:20 ET | Mount Sinai Health System
NEW YORK, May 19, 2023 (GLOBE NEWSWIRE) -- The Mount Sinai Health System today held a grand opening of the expansion of the Mount Sinai Brooklyn Ambulatory Infusion Center, a cancer treatment center...